<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There are conflicting evidences on endothelial function in <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This may be attributed to the effects of risk factors on the vascular smooth muscle </plain></SENT>
<SENT sid="2" pm="."><plain>To test endothelial function only in patients with <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e>, we evaluated the endothelium-dependent and -independent vasodilatation of the brachial artery </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We enrolled consecutive patients with <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> defined by clinical characteristics and MRI findings </plain></SENT>
<SENT sid="4" pm="."><plain>The control group included age- and sex-matched patients with <z:hpo ids='HP_0000822'>hypertension</z:hpo> who do not have any history of clinical <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> or <z:hpo ids='HP_0004950'>peripheral vascular disease</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Endothelial function was evaluated using flow-mediated <z:mpath ids='MPATH_66'>dilatation</z:mpath> (FMD) and nitrogen-mediated <z:mpath ids='MPATH_66'>dilatation</z:mpath> (NMD) of the brachial artery </plain></SENT>
<SENT sid="6" pm="."><plain>FMD and NMD were examined by an experienced vascular sonographer using a high-resolution ultrasound </plain></SENT>
<SENT sid="7" pm="."><plain>Intracranial stenosis was defined as flow gap or &gt;50% reduction in vessel diameter on MRA </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: FMD was 6.6 +/- 4.5% in the <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> group and 12.2 +/- 4.6% in the control group (p = 0.000) </plain></SENT>
<SENT sid="9" pm="."><plain>NMD was 14.3 +/- 4.9% in the <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> group and 13.8 +/- 4.9% in the control group (p = 0.37) </plain></SENT>
<SENT sid="10" pm="."><plain>FMD in patients with <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> and intracranial <z:hpo ids='HP_0100545'>arterial stenosis</z:hpo> was 6.4 +/- 3.9%, and FMD in patients with <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> was only 6.9 +/- 5.5% </plain></SENT>
<SENT sid="11" pm="."><plain>In the control group, it was 12.2 +/- 4.6% </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: FMD was low in patients with <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>NMD was similar between the <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> group and the control group </plain></SENT>
<SENT sid="14" pm="."><plain>These results are suggestive of pure <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain><z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">Endothelial dysfunction</z:e> was as severe in <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> as in intracranial <z:hpo ids='HP_0100545'>arterial stenosis</z:hpo> </plain></SENT>
</text></document>